Dr. Shaywitz is trained in internal medicine and endocrinology at MGH, and conducted his post-doctoral research in the Melton lab at Harvard. He gained experience in early clinical drug development in the Department of Experimental Medicine at Merck, then joined the Boston Consulting Group’s Healthcare and Corporate Development practices, where he focused on strategy and organizational design. Most recently, he was Senior Director of Strategic and Commercial Planning and Corporate and Business Development at Theravance, a publicly-held drug development company in South San Francisco, where he concentrated on new product development and led a product team. He's also the Chief Medical Officer of Mountain View-based DNAnexus, where he focuses on delivering upon the collaborative, patient-inspired vision of genome-enabled (really, data-enabled) medicine.
Send this to a friend